danazol has been researched along with warfarin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Katz, MD; Mahaffey, KW; Meeks, ML | 1 |
| Hiekata, T; Hinata, S; Kamata, S; Mieda, T | 1 |
| Goldrath, MH | 1 |
| Hewitt, B; Manoharan, A | 1 |
| Mari, A; Vernotico, V; Zanella, B | 1 |
| Gounder, M; Hultin, MB; Miller, N; Zarrabi, MH | 1 |
| Lowe, GD; McCune, G; Peterkin, M; Small, M; Thomson, JA | 1 |
| Goulbourne, IA; Macleod, DA | 1 |
| Brito, M; Delgado, L; Horton, A; Ledford, MR; Wang, G | 1 |
| Alvarado, RG; Liu, JY; Zwolak, RM | 1 |
1 review(s) available for danazol and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for danazol and warfarin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Danazol increases the anticoagulant effect of warfarin.
Topics: Adult; Cerebrovascular Disorders; Danazol; Drug Synergism; Female; Humans; Middle Aged; Prothrombin Time; Warfarin | 1992 |
[Subarachnoid hemorrhage following commencement of danazol treatment in a patient well controlled on warfarin anticoagulation].
Topics: Aortic Valve Insufficiency; Blood Coagulation; Danazol; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve Insufficiency; Subarachnoid Hemorrhage; Warfarin | 1991 |
Use of danazol in hysteroscopic surgery for menorrhagia.
Topics: Adolescent; Adult; Danazol; Drug Synergism; Endometriosis; Female; Humans; Hysteroscopy; Laser Therapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Pregnadienes; Premedication; Uterine Hemorrhage; Warfarin | 1990 |
Danazol therapy in familial antithrombin III deficiency.
Topics: Antithrombin III Deficiency; Danazol; Drug Therapy, Combination; Humans; Male; Middle Aged; Thromboembolism; Warfarin | 1990 |
[Danazol in the treatment of menometrorrhagia in patients with mitral prosthesis treated with warfarin].
Topics: Anemia, Hypochromic; Danazol; Drug Evaluation; Drug Interactions; Female; Heart Valve Prosthesis; Humans; Menorrhagia; Mitral Valve; Mitral Valve Stenosis; Pregnadienes; Warfarin | 1989 |
Hereditary antithrombin III deficiency: case report and review of recent therapeutic advances.
Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Danazol; Humans; Male; Warfarin | 1986 |
Danazol and oral anticoagulants.
Topics: Administration, Oral; Adult; Anticoagulants; Blood Coagulation Tests; Danazol; Drug Interactions; Female; Hematuria; Humans; Menorrhagia; Pregnadienes; Pulmonary Embolism; Warfarin | 1982 |
An interaction between danazol and warfarin. Case report.
Topics: Adult; Danazol; Drug Interactions; Endometriosis; Female; Heart Valve Diseases; Hematemesis; Humans; Pregnadienes; Prothrombin Time; Warfarin | 1981 |
Efficacy of danazol in a patient with congenital protein-S deficiency: paradoxical evidence for decreased platelet activation with increased thrombin generation.
Topics: Adult; Anticoagulants; Cell Separation; Danazol; Estrogen Antagonists; Fibrinolysis; Flow Cytometry; Humans; Male; P-Selectin; Platelet Activation; Protein S Deficiency; Thrombin; Warfarin | 1997 |
Danazol and limb-threatening arterial thrombosis: two case reports.
Topics: Acute Disease; Adult; Aged; Angiography; Anticoagulants; Arteries; Danazol; Drug Therapy, Combination; Endometriosis; Estrogen Antagonists; Female; Heparin; Humans; Leg; Pain; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Thrombosis; Urokinase-Type Plasminogen Activator; Warfarin | 2001 |